Ajibola Saka S, Timothy Fajemirokun O
Department of Clinical Pharmacy/Biopharmacy, Olabisi Onabanjo University, Sagamu Campus, Ogun State, Nigeria.
J Patient Exp. 2018 Jun;5(2):114-119. doi: 10.1177/2374373517732384. Epub 2017 Sep 29.
Medication adherence (MA) is a challenge among patients with chronic diseases worldwide. Little has been reported on the influence of National Health Insurance Scheme (NHIS) on MA among diabetic patients in Nigeria.
To assess the influence of NHIS on MA among outpatient type 2 diabetics in 2 public secondary health facilities in Southwest Nigeria.
A cross-sectional study involving 110 consecutively selected outpatient type 2 diabetics (insured, n = 42; uninsured, n = 68) was carried out. The patients' perceptions of care and the influence of drug cost on MA between the insured and uninsured were compared. The patients' perceptions of care were assessed using a 25-item pretested questionnaire. The MA was measured using the Morisky MA-8 scale. The use of oral antidiabetic drugs (OADs) was evaluated using a medical chart review. Information about patients' sociodemographics, year of diagnosis, comorbidities, and types of OADs prescribed was retrieved from the medical records. Descriptive statistics were used for data presentation. A Pearson χ was used for test of associations. values < .05 were considered significant.
Majority of the respondents (68 [61.8%]) were uninsured. The insured and the uninsured patients differed in their perceptions of the adequacy of time used by pharmacists for medication counseling ( < .0005). The MA between the groups also differs ( = .0002). The monthly drug cost for OADs was significantly associated with MA ( = .037).
The study concluded that the NHIS may positively influence MA among diabetic patients. The drug cost may have contributed significantly to the difference in MA between the groups. More time should be devoted to the counseling of the uninsured patients.
药物依从性(MA)是全球慢性病患者面临的一项挑战。关于尼日利亚国家健康保险计划(NHIS)对糖尿病患者药物依从性的影响,鲜有报道。
评估NHIS对尼日利亚西南部两家公立二级卫生机构门诊2型糖尿病患者药物依从性的影响。
开展了一项横断面研究,连续选取了110名门诊2型糖尿病患者(参保者,n = 42;未参保者,n = 68)。比较了参保者和未参保者对护理的认知以及药物成本对药物依从性的影响。使用一份经过预测试的包含25个条目的问卷评估患者对护理的认知。使用Morisky药物依从性-8量表测量药物依从性。通过查阅病历评估口服抗糖尿病药物(OADs)的使用情况。从病历中获取患者的社会人口统计学信息、诊断年份、合并症以及所开OADs的类型。使用描述性统计呈现数据。使用Pearson χ检验进行关联性检验。p值 <.05被视为具有显著性。
大多数受访者(68 [61.8%])未参保。参保患者和未参保患者在对药剂师进行用药咨询所用时间是否充足的认知上存在差异(p <.0005)。两组之间的药物依从性也存在差异(p =.0002)。OADs的每月药物成本与药物依从性显著相关(p =.037)。
该研究得出结论,NHIS可能对糖尿病患者的药物依从性产生积极影响。药物成本可能是两组之间药物依从性差异的重要原因。应投入更多时间为未参保患者提供咨询服务。